Jazz Pharmaceuticals ( JAZZ) was initiated with a buy rating at Cantor Fitzgerald. JAZZ is an attractive growth story that has been held back by generic concerns over its key revenue driver, Xyrem, Cantor Fitzgerald said. Price target is $86.

Mylan ( MYL) was downgraded at Canaccord to neutral. Fewer catalysts are ahead, making upside from here limited, Canaccord said.

STOCK COMMENTS/EPS CHANGES

Accenture ( ACN) price target was increased at Deutsche Bank. The update comes ahead of earnings, Deutsche Bank said. Shares should rebound on a pick-up in demand in the second half of 2013, Deutsche added. New price target is $87.

Aflac ( AFL) estimates were updated at Deutsche Bank. Estimates through 2015 were decreased. The new numbers reflecting the updated DB house views on the further weakening of the yen, Deutsche Bank said.

Salesforce.com ( CRM) price target was increased at Jefferies to $215. CRM released a 10-K with some additional data around regional revenue, headcount and expenses, Jefferies said.

McDonald's ( MCD) price target was increased to $108 at Deutsche Bank. February sales showed the U.S. business is getting back on track, Deutsche Bank said. Easier compares in the second quarter and attractive valuation keeps it a buy-rated stock, Deutsche said.